A multifaceted evaluation that includes ultra-widefield imaging can reveal new information and influence treatment decisions.
Modern Retina Spring 2022
In the face of the COVID-19 pandemic, the procedure required adjustments.
The implant achieves impressive efficacy and reduces treatment burden.
Investigational pipeline provides promise for an unmet need.
The first FDA-approved bispecific antibody for the eye targets two leading causes of vision loss.
Advertisement
Advertisement
Trending on Modern Retina
1
Genetic Retinoblastoma Risk Stratified by Age Among Patients with Metachronous Bilateral Conversion
2
Galimedix Therapeutics earns milestone payment in ophthalmology partnership with Théa Open Innovation
3
Eichenbaum Acorns: Collaborative retina care with Jeffry D. Gerson, OD, FAAO
4
NovaBridge, Visara report positive phase 2a results for dual VEGF-A/ANG-2 inhibitor VIS-101
5